Breast cancer is the most common cancer affecting women worldwide, with millions of new cases diagnosed every year. Early detection is one of the most effective ways to improve outcomes, yet traditional screening methods such as mammograms can sometimes be uncomfortable or difficult to access.

Poor blood flow often first appears in the feet, where it may signal conditions like diabetes or vascular disease. Early detection can improve long-term health outcomes.

Testicular cancer is the most common cancer in young men, with early symptoms including lumps, swelling, or discomfort in the testicle, scrotum, abdomen, or back. Early recognition improves treatment success rates.

Davion Healthcare Plc, Unit A West Cork Business & Technology Park Clonakilty, County Cork P85 FV48, Ireland

Davion Healthcare Plc has signed an agreement to acquire 100% of Humaskan Ltd, a medical technology company. The acquisition strengthens Davion's portfolio of non-invasive remote health monitoring solutions and healthcare IP.

Davion Healthcare Plc has signed an agreement to acquire 100% of Humaskan Ltd, a medical technology company. The acquisition strengthens Davion's portfolio of non-invasive remote health monitoring solutions and healthcare IP.

Davion Healthcare Plc acquires **Healthcare Stat Homecare Inc.**, a Pennsylvania-based home healthcare provider in Philadelphia, for **$13.5 million**. The company specializes in non-invasive health monitoring technologies and expands its service portfolio through this acquisition. The deal strengthens Davion’s presence in the US home healthcare market.

Oct 2026MorningstarNews article

Davion Healthcare has finalized a $25 million asset acquisition. The transaction includes cash payment terms due by February 19, 2027, alongside restrictions on seller post-issuance sales for 90 days, capped by daily trading volume limits.

Oct 2026StockTitanNews article

Davion Healthcare completes a **$25 million acquisition** of Humaskan Medical Technology’s intellectual property, including **WoundSkan**, a smart wound-monitoring dressing, and **Spektra**, a rapid multi-marker screening platform. The deal expands Davion’s portfolio of proprietary health-monitoring technologies. Davion, a digital healthcare company, integrates these assets into its existing product pipeline.

Oct 2026Business InsiderNews article

Davion Healthcare PLC confirms its ordinary shares will begin trading on Nasdaq Global Market on **22 October 2026** under the ticker **DAVI**. The company also introduces a restructured executive leadership team and new operating framework to support its market debut.

Oct 2026Davion Healthcare PlcNews article